Informationen:
Fehler:
ID
30417
Beschreibung
Chemotherapy for Patients With Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00436280
Link
https://clinicaltrials.gov/show/NCT00436280
Stichworte
Versionen (1)
- 04.06.18 04.06.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
4. Juni 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Lymphoma, Large Cell, Diffuse NCT00436280
Eligibility Lymphoma, Large Cell, Diffuse NCT00436280
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Lymphoma, Large Cell, Diffuse NCT00436280
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Diffuse Large B-Cell Lymphoma | Indolent Lymphoma CD20 antigen positive Transformed
Item
diagnosis of dlbcl or transformed (cd20+) indolent lymphoma
boolean
C0079744 (UMLS CUI [1])
C1334170 (UMLS CUI [2,1])
C3888518 (UMLS CUI [2,2])
C0457344 (UMLS CUI [2,3])
C1334170 (UMLS CUI [2,1])
C3888518 (UMLS CUI [2,2])
C0457344 (UMLS CUI [2,3])
Recurrent disease | Disease Progression | Status post Disease Response First line treatment | Status post Disease Response Second line treatment | Disease Progression Absent | Status post Stable Disease First line treatment | Status post Stable Disease Second line treatment
Item
relapsed/progressed after response obtained in 1st- or 2nd-line treatment, or patients who have not progressed after sd obtained in 1st- or 2nd-line.
boolean
C0277556 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C1704632 (UMLS CUI [3,2])
C1708063 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C1704632 (UMLS CUI [4,2])
C1710038 (UMLS CUI [4,3])
C0242656 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0231290 (UMLS CUI [6,1])
C0677946 (UMLS CUI [6,2])
C1708063 (UMLS CUI [6,3])
C0231290 (UMLS CUI [7,1])
C0677946 (UMLS CUI [7,2])
C1710038 (UMLS CUI [7,3])
C0242656 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C1704632 (UMLS CUI [3,2])
C1708063 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C1704632 (UMLS CUI [4,2])
C1710038 (UMLS CUI [4,3])
C0242656 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0231290 (UMLS CUI [6,1])
C0677946 (UMLS CUI [6,2])
C1708063 (UMLS CUI [6,3])
C0231290 (UMLS CUI [7,1])
C0677946 (UMLS CUI [7,2])
C1710038 (UMLS CUI [7,3])
Measurable Disease | Size of lymph node
Item
measurable disease (lymph node greater than 1.5 cm)
boolean
C1513041 (UMLS CUI [1])
C1285847 (UMLS CUI [2])
C1285847 (UMLS CUI [2])
Organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Age | Ineligibility High-dose chemotherapy | Ineligibility Transplantation of autologous hematopoietic stem cell
Item
greater than or equal to 60 years or less than 60 (but greater than or equal to 18 years) who are not eligible for hdc and asct
boolean
C0001779 (UMLS CUI [1])
C1512714 (UMLS CUI [2,1])
C1328050 (UMLS CUI [2,2])
C1512714 (UMLS CUI [3,1])
C1831743 (UMLS CUI [3,2])
C1512714 (UMLS CUI [2,1])
C1328050 (UMLS CUI [2,2])
C1512714 (UMLS CUI [3,1])
C1831743 (UMLS CUI [3,2])
Transplantation, Homologous
Item
prior allogeneic transplantation
boolean
C0040739 (UMLS CUI [1])
Cancer treatment Quantity
Item
more than 2 prior anticancer treatment regimens
boolean
C0920425 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
HIV Associated with Lymphoma
Item
human-immunodeficiency-virus (hiv)associated lymphomas
boolean
C0019682 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0332281 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain
Item
brain metastases
boolean
C0220650 (UMLS CUI [1])